DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Ultrasound and Neuraxial Anesthesia in Pregnancy

Completed

Conditions: Infusion Site Anaesthesia

Interventions: Other: Education

First Posted Date: 2015-03-19

Last Posted Date: 2019-09-26

Lead Sponsor: University of Chicago

Target Recruit Count: 450

Registration Number: NCT02392533

Locations: 🇺🇸
The University of Chicago MEDICINE, Chicago, Illinois, United States

Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant

Phase 2

Active, not recruiting

Conditions: Plasma Cell Myeloma
Residual Disease

Interventions: Drug: Ixazomib Citrate
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2015-03-17

Last Posted Date: 2024-08-15

Lead Sponsor: University of Chicago

Target Recruit Count: 42

Registration Number: NCT02389517

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4

Recruiting

Conditions: Stage IIIA Esophageal Adenocarcinoma
Esophageal Adenocarcinoma
Stage IIIC Gastric Cancer
Gastric Adenocarcinoma
Stage IIIB Esophageal Adenocarcinoma
Stage IIIC Esophageal Adenocarcinoma
Stage IIB Gastric Cancer
Stage IIIB Gastric Cancer
Stage IIIA Gastric Cancer

Interventions: Drug: Oxaliplatin
Drug: Leucovorin Calcium
Drug: Irinotecan Hydrochloride
Drug: Fluorouracil
Procedure: Conventional Surgery

First Posted Date: 2015-02-19

Last Posted Date: 2024-05-02

Lead Sponsor: University of Chicago

Target Recruit Count: 36

Registration Number: NCT02366819

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
Kellogg Cancer Center - Evanston Hospital, Evanston, Illinois, United States
🇺🇸
NorthShore University HealthSystem, Evanston, Illinois, United States

Implementing Diabetes Group Visits in Community Health Centers

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Diabetes group visit

First Posted Date: 2015-01-27

Last Posted Date: 2018-05-09

Lead Sponsor: University of Chicago

Target Recruit Count: 139

Registration Number: NCT02347514

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Delayed Cord Clamping in Very Low Birth Weight Infants

Not Applicable

Terminated

Conditions: Intraventricular Hemorrhage
Very Low Birth Weight Infants
Premature Infants

Interventions: Procedure: Delayed cord clamping at 60 seconds
Procedure: Delayed cord clamping at 30 seconds

First Posted Date: 2015-01-13

Last Posted Date: 2017-08-29

Lead Sponsor: University of Chicago

Target Recruit Count: 39

Registration Number: NCT02337088

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Milk Thistle in Pathological Gambling

Phase 2

Completed

Conditions: Pathological Gambling
Gambling Disorder

Interventions: Drug: Placebo
Drug: Milk Thistle

First Posted Date: 2015-01-13

Last Posted Date: 2023-05-12

Lead Sponsor: University of Chicago

Target Recruit Count: 43

Registration Number: NCT02337634

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Phase 1

Completed

Conditions: Adenocarcinoma of Unknown Primary
Adult Cholangiocarcinoma
Gallbladder Carcinoma
Malignant Gastrointestinal Neoplasm
Metastatic Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Gastric Adenocarcinoma
Stage III Ampulla of Vater Cancer
Stage III Pancreatic Cancer
Stage IIIA Gallbladder Cancer

Interventions: Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Drug: Leucovorin Calcium
Drug: Irinotecan Hydrochloride
Drug: Fluorouracil
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-01-07

Last Posted Date: 2023-05-31

Lead Sponsor: University of Chicago

Target Recruit Count: 50

Registration Number: NCT02333188

Locations: 🇺🇸
Ingalls Memorial Hospital, Harvey, Illinois, United States
🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States
🇺🇸
Virginia Mason, Seattle, Washington, United States

and more 5 locations

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Phase 1

Recruiting

Conditions: Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Hematologic Malignancy
Recurrent Adult Acute Myeloid Leukemia
Previously Treated Myelodysplastic Syndrome

Interventions: Drug: Fludarabine Phosphate
Drug: Melphalan
Radiation: Intensity-Modulated Radiation Therapy
Radiation: Total Marrow Irradiation
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Procedure: Peripheral Blood Stem Cell Transplantation
Procedure: Allogeneic Bone Marrow Transplantation
Drug: Tacrolimus
Drug: Mycophenolate Mofetil
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-01-07

Last Posted Date: 2025-02-05

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT02333162

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer

Completed

Conditions: Free Tissue Flaps
Head and Neck Neoplasms

First Posted Date: 2015-01-06

Last Posted Date: 2023-04-18

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT02332161

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans

Not Applicable

Completed

Conditions: Substance Abuse

Interventions: Drug: methamphetamine
Drug: placebo

First Posted Date: 2014-12-23

Last Posted Date: 2018-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 90

Registration Number: NCT02323048

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy